New blood cancer treatment appears successful for most trial patients

First-line treatment for patients with advanced RCC “Keytruda plus Lenvima continues to demonstrate durable clinical benefit as a first-line treatment for patients with advanced renal cell carcinoma, as shown by the...

Tradipitant Prevents Motion Sickness in Phase 3 Trail Tradipitant was found to be superior to placebo in preventing vomiting associated with motion sickness, according to results from a phase 3 study. The double-blind...

Resiniferatoxin Gets Breakthrough Therapy Status for Knee Osteoarthritis Pain The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to resiniferatoxin for the treatment of pain associated...